NLS Pharmaceutics Ltd. SC 13G and SC 13G/A reports

Location
The Circle 6, 8058, Zurich, Switzerland
State of incorporation
Switzerland
Fiscal year end
December 31
Data updated at
9/20/2024, 01:21 AM
Form type Sec Links Description Filing date Reporting date
SC 13G Report Mar 27, 2024
SC 13G/A Report SC 13G/A Feb 12, 2024
SC 13G Report SCHEDULE 13G Feb 24, 2023
SC 13G/A Report AMENDMENT NO. 1 TO SCHEDULE 13G Feb 14, 2023
SC 13G/A Report AMENDMENT NO. 1 TO SCHEDULE 13G Feb 14, 2023
SC 13G/A Report AMENDMENT NO. 1 TO SCHEDULE 13G Feb 13, 2023
SC 13G/A Report SC 13G/A Jan 3, 2023
SC 13G Report THE SCHEDULE 13G Dec 16, 2022
SC 13G Report SCHEDULE 13G Feb 24, 2022
SC 13G Report SCHEDULE 13G Feb 18, 2022
SC 13G Report SCHEDULE 13G Feb 14, 2022
SC 13G/A Report SCHEDULE 13G Jan 11, 2022
SC 13G Report SC 13G Oct 8, 2021
SC 13G/A Report AMENDMENT TO FORM SC 13G Mar 17, 2021
SC 13G Report SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP Feb 4, 2021